Semaglutide & Tirzepatide: Effect on Blood Sugar Management Semaglutide is excellent in controlling blood glucose levels by stimulating the pancreas to release insulin when sugar levels are high
Among patients with PV, those receiving GLP-1a therapy experienced lower rates of several adverse outcomes compared with non-users
Tirzepatide (Mounjaro) is a game changer in obesity and type 2 diabetes treatment
Avoid contact with strong oxidizing agents
Lee, MD, MPH, a professor of pediatrics and communicable diseases at the University of Michigan School of Public Health, and colleagues, interest in GLP-1 receptor agonists have soared in the past decade, especially after the 2021 approval of semaglutide (Wegovy, Novo Nordisk) for weight management in adults
Patients with high-responder profiles typically see results in 23 weeks, while lower responders may require 8+ weeks or alternative compounds